AT Bancorp’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-7,890
Closed -$344K 239
2017
Q4
$344K Buy
7,890
+137
+2% +$6.4K 0.04% 190
2017
Q3
$406K Sell
7,753
-932
-11% -$52K 0.05% 174
2017
Q2
$508K Sell
8,685
-13,719
-61% -$713K 0.06% 154
2017
Q1
$1.03M Hold
22,404
0.13% 146
2016
Q4
$1.18M Sell
22,404
-5,168
-19% -$250K 0.16% 116
2016
Q3
$1.23M Buy
+27,572
New +$1.2M 0.17% 128

Other funds holding SYNH

AT Bancorp's SYNH Position: Q1 2018 in Review

AT Bancorp sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q1 2018, closing a stake of 7,890 shares — an estimated $344K sold.

AT Bancorp first reported a position in SYNH in Q3 2016 and held it in 6 quarters. The position peaked at $1.23M in Q3 2016. 218 funds tracked by Wall St. Rank hold SYNH as of Q1 2018.

  • AT Bancorp reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q1 2018 after selling out during the quarter.
  • AT Bancorp sold 7,890 Syneos Health, Inc. Class A Common Stock shares in Q1 2018, an estimated $344K.
  • AT Bancorp first reported a position in Syneos Health, Inc. Class A Common Stock in Q3 2016 and held it in 6 quarters.
  • AT Bancorp's Syneos Health, Inc. Class A Common Stock position peaked at $1.23M in Q3 2016.
  • 218 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q1 2018.

Based on AT Bancorp's 13F filing for Q1 2018, filed 9 May 2018.